Peritoneal fluid’s predictive role

Fluid drawn from the abdomen can do more than explain swelling: under a microscope, it can show whether cancer has already seeded the peritoneal cavity. (sciencedirect.com) That fluid is called ascites when it builds up naturally, and peritoneal washings when surgeons rinse the abdominal lining and collect the washback during an operation. Cytology is the lab test that looks for abnormal cells floating in those samples. (cytojournal.com) In women with gynecologic cancers, peritoneal fluid samples are often the first — and sometimes the only — material a pathologist has before treatment decisions are made. A 2023 review said the cytology report can affect both diagnosis and staging. (karger.com) The new Journal of the American Society of Cytopathology paper, published online in April 2026, focuses on malignant ovarian germ cell tumors, a rarer group than the adenocarcinomas that usually dominate malignant effusions. The authors said systematic data on peritoneal cytology in that setting had been limited mostly to case reports. (sciencedirect.com) The basic clinical question is simple: if tumor cells are floating in abdominal fluid, the disease may have reached surfaces beyond the original mass. In peritoneal washings, that information has long been used to judge disease extent and help guide follow-up therapy. (cytojournal.com) Doctors do not use cytology by itself to explain every case of ascites, because most ascites is not caused by cancer. Pathology Outlines says malignancy accounts for about 2.4% of ascites causes in the United States, while cirrhosis is far more common. (pathologyoutlines.com) That is why the first workup for new ascites usually includes several tests at once, not just a cancer screen. Medscape’s summary of major liver and gastroenterology guidance says clinicians commonly send fluid for cell count, albumin, culture, total protein, Gram stain, and cytology. (medscape.com) How the sample is collected also changes how useful the test will be. A 2019 prospective study of 123 patients found cytology sensitivity rose with larger sample volumes and leveled off at about 200 milliliters, which the authors recommended as the minimum volume for confirming malignant ascites. (pmc.ncbi.nlm.nih.gov) Pathologists also have to separate true cancer cells from lookalikes. Peritoneal washings can contain reactive mesothelial cells, endometriosis, endosalpingiosis, or cells released after tumor rupture, all of which can mimic malignancy if the clinical setting is ignored. (cytojournal.com) So the message from the latest alert is narrower than “fluid equals cancer.” In the right patient, with enough sample and the right clinical context, peritoneal fluid cytology can show intraperitoneal spread before a larger tissue diagnosis is available. (sciencedirect.com)